To engage and develop customers, from initial identification through to developing as advocates, delivering educational activities, communicating key messages and gaining meaningful advice
Developing customers
To engage and develop customers to deliver a variety of educational activities, to communicate key messages and become true advocates
Identification and mapping
Individuals, networks, groups, centres. Whether looking to identify a new group to support a novel therapy area/indication or to validate an existing target list.
Engagement and involvement
To develop training and educational initiatives of real interest to HCPs, to better engage and involve them and develop as true advocates.
Advice and direction
From a one-off activity at short notice to ongoing support and direction for the duration of a product lifecycle.
Mobilising support
Harnessing opportunities to communicate key messages, offering education to a wider audience and gain peer to peer support, to include meetings F2F, hybrid and virtual.
Developing platforms and outputs
An opportunity to communicate key messages, shift practice, change perceptions across a variety of formats.
Customer insights
To provide meaningful and validated insights based on a combination of focused desk work, targeted interviews and meetings with experts.
To provide Rapid Insights reflecting the increasingly dynamic & competitive environment clients operate in, to aid the decision process, to fine tune development pathways or to assist a BD&L opportunity.
Identifying/defining opportunities
New markets, new products, new opportunities, this could be broad landscape or specific.
Defining, sizing markets
To gain information on market dimensions and opportunity based on patient population and expert insights.
Understanding treatment processes, patient pathways
What are the major opportunities, barriers and key trigger points.
Understanding the environment
To identify key influences, influencers and trends, now and in the future.
Specific need
Such as customer reactions to latest guidance, emerging clinical data or competitor activity.